|
Originally published In Press as doi:10.1074/jbc.M107778200 on September 18, 2001
J. Biol. Chem., Vol. 276, Issue 46, 43160-43165, November 16, 2001
Biodistribution, Kinetics, and Efficacy of Highly
Phosphorylated and Non-phosphorylated -Glucuronidase in the Murine
Model of Mucopolysaccharidosis VII*
Mark S.
Sands §¶,
Carole A.
Vogler ,
Kevin K.
Ohlemiller**,
Marie S.
Roberts ,
Jeffrey H.
Grubb ,
Beth
Levy , and
William S.
Sly
From the Departments of Internal Medicine and
§ Genetics, and the ** Research Department,
Central Institute for the Deaf, Washington University School of
Medicine, St. Louis, Missouri 63110 and the Department of
Pathology and the  Edward A. Doisy Department of
Biochemistry and Molecular Biology, St. Louis University School of
Medicine, St. Louis, Missouri 63104
Enzyme replacement therapy (ERT) has been shown
to be effective at reducing the accumulation of undegraded substrates
in lysosomal storage diseases. Most ERT studies have been performed
with recombinant proteins that are mixtures of phosphorylated and
non-phosphorylated enzyme. Because different cell types use different
receptors to take up phosphorylated or non-phosphorylated enzyme, it is
difficult to determine which form of enzyme contributed to the clinical response. Here we compare the uptake, distribution, and efficacy of
highly phosphorylated and non-phosphorylated -glucuronidase (GUSB) in the MPS VII mouse. Highly phosphorylated murine GUSB was
efficiently taken up by a wide range of tissues. In contrast, non-phosphorylated murine GUSB was taken up primarily by tissues of the
reticuloendothelial (RE) system. Although the tissue distribution was
different, the half-lives of both enzymes in any particular tissue were
similar. Both preparations of enzyme were capable of preventing the
accumulation of lysosomal storage in cell types they targeted. An
important difference in clinical efficacy emerged in that
phosphorylated GUSB was more efficient than non-phosphorylated enzyme
at preventing the hearing loss associated with this disease. These data
suggest that both forms of enzyme contribute to the clinical responses
of ERT in MPS VII mice but that enzyme preparations containing
phosphorylated GUSB are more broadly effective than non-phosphorylated enzyme.
*
This work was supported by National Institutes of Health
Grants RO1 HD35671 (to M. S. S.) and RO1 GM34182 (to W. S. S.) and The Edward Mallinckrodt Jr. Foundation (to K. K. O.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Internal
Medicine, Washington University School of Medicine, Box 8007, 660 South
Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-5494; Fax:
314-362-9333; E-mail: msands@imgate.wustl.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. H. Grubb, C. Vogler, Y. Tan, G. N. Shah, A. F. MacRae, and W. S. Sly
Infused Fc-tagged {beta}-glucuronidase crosses the placenta and produces clearance of storage in utero in mucopolysaccharidosis VII mice
PNAS,
June 17, 2008;
105(24):
8375 - 8380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tomatsu, A. M. Montano, A. Ohashi, M. A. Gutierrez, H. Oikawa, T. Oguma, V. C. Dung, T. Nishioka, T. Orii, and W. S. Sly
Enzyme replacement therapy in a murine model of Morquio A syndrome
Hum. Mol. Genet.,
March 15, 2008;
17(6):
815 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Urayama, J. H. Grubb, W. A. Banks, and W. S. Sly
Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor
PNAS,
July 31, 2007;
104(31):
12873 - 12878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Sly, C. Vogler, J. H. Grubb, B. Levy, N. Galvin, Y. Tan, T. Nishioka, and S. Tomatsu
Enzyme therapy in mannose receptor-null mucopolysaccharidosis VII mice defines roles for the mannose 6-phosphate and mannose receptors
PNAS,
October 10, 2006;
103(41):
15172 - 15177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. LeBowitz
A breach in the blood-brain barrier
PNAS,
October 11, 2005;
102(41):
14485 - 14486.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Matzner, E. Herbst, K. K. Hedayati, R. Lullmann-Rauch, C. Wessig, S. Schroder, C. Eistrup, C. Moller, J. Fogh, and V. Gieselmann
Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy
Hum. Mol. Genet.,
May 1, 2005;
14(9):
1139 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhu, X. Li, J. Kyazike, Q. Zhou, B. L. Thurberg, N. Raben, R. J. Mattaliano, and S. H. Cheng
Conjugation of Mannose 6-Phosphate-containing Oligosaccharides to Acid {alpha}-Glucosidase Improves the Clearance of Glycogen in Pompe Mice
J. Biol. Chem.,
November 26, 2004;
279(48):
50336 - 50341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Urayama, J. H. Grubb, W. S. Sly, and W. A. Banks
Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier
PNAS,
August 24, 2004;
101(34):
12658 - 12663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Prince, L. M. McCormick, D. J. Wendt, P. A. Fitzpatrick, K. L. Schwartz, A. I. Aguilera, V. Koppaka, T. M. Christianson, M. C. Vellard, N. Pavloff, et al.
Lipoprotein Receptor Binding, Cellular Uptake, and Lysosomal Delivery of Fusions between the Receptor-associated Protein (RAP) and {alpha}-L-Iduronidase or Acid {alpha}-Glucosidase
J. Biol. Chem.,
August 13, 2004;
279(33):
35037 - 35046.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M.P. Van den Hout, J. H.J. Kamphoven, L. P.F. Winkel, W. F.M. Arts, J. B.C. D. Klerk, M. C. B. Loonen, A. G. Vulto, A. Cromme-Dijkhuis, N. Weisglas-Kuperus, W. Hop, et al.
Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human {alpha}-Glucosidase From Milk
Pediatrics,
May 1, 2004;
113(5):
e448 - e457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. LeBowitz, J. H. Grubb, J. A. Maga, D. H. Schmiel, C. Vogler, and W. S. Sly
Glycosylation-independent targeting enhances enzyme delivery to lysosomes and decreases storage in mucopolysaccharidosis type VII mice
PNAS,
March 2, 2004;
101(9):
3083 - 3088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dhami and E. H. Schuchman
Mannose 6-Phosphate Receptor-mediated Uptake Is Defective in Acid Sphingomyelinase-deficient Macrophages: IMPLICATIONS FOR NIEMANN-PICK DISEASE ENZYME REPLACEMENT THERAPY
J. Biol. Chem.,
January 9, 2004;
279(2):
1526 - 1532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Ponder, J. R. Melniczek, L. Xu, M. A. Weil, T. M. O'Malley, P. A. O'Donnell, V. W. Knox, G. D. Aguirre, H. Mazrier, N. M. Ellinwood, et al.
From the Cover: Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs
PNAS,
October 1, 2002;
99(20):
13102 - 13107.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|